Details for Patent: 8,470,368
✉ Email this page to a colleague
Summary for Patent: 8,470,368
Title: | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Abstract: | A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described. |
Inventor(s): | Kositprapa; Unchalee (Davie, FL), Goldfarb; Robert I. (Golden Beach, FL), Cardinal; John R. (Tamarac, FL), Nangia; Avinash (Weston, FL) |
Assignee: | Watson Pharmaceuticals, Inc. (Corona, CA) |
Application Number: | 13/151,653 |
Patent Claim Types: see list of patent claims | Composition; Compound; Dosage form; Formulation; Device; |
Drugs Protected by US Patent 8,470,368
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,470,368
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 054238 | ⤷ Sign Up | |||
Australia | 2003272504 | ⤷ Sign Up | |||
Australia | 2004283059 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |